Temazepam: Uses, Dosage, and Side Effects Info
Table of Contents
Introduction
Temazepam is a prescription medication used to treat insomnia, a sleep disorder characterized by difficulty falling asleep or staying asleep. It belongs to the benzodiazepine class of drugs, which work by enhancing the effects of GABA, a neurotransmitter that promotes relaxation and sleep. Temazepam is known by various brand names, including Restoril, and is typically prescribed for short-term use, usually for 7 to 10 days.
Medical Uses
Primary Use: Treatment of Insomnia
Temazepam is primarily used to treat severe or debilitating insomnia, helping patients fall asleep faster and maintain sleep throughout the night. It is considered an effective short-term remedy for insomnia, with studies showing improved sleep latency, duration, and quality [1].
Off-Label Uses
In some cases, temazepam may be prescribed off-label for other conditions, such as anxiety, restless leg syndrome, or periodic limb movement disorder. However, these uses are not officially approved by the FDA.
Dosage and Administration
Recommended Dosage
The recommended initial dose of temazepam for adults is 7.5-30 mg, taken orally before bedtime. The dose may be adjusted based on individual response and tolerability, with a maximum dose of 30 mg per day [2].
Instructions for Use
Temazepam should be taken immediately before bedtime and only when the patient has 7-8 hours to dedicate to sleep. It is important to follow the prescribed dose and not exceed the recommended duration of treatment to minimize the risk of dependence and withdrawal symptoms.
Side Effects
Common Side Effects
Common side effects of temazepam include drowsiness, dizziness, lightheadedness, and unsteadiness. Patients may also experience impaired coordination and reduced alertness, especially when first starting the medication [3].
Serious Side Effects
Serious side effects of temazepam are rare but may include respiratory depression, memory impairment, and paradoxical reactions such as agitation or hallucinations. If any of these occur, patients should seek immediate medical attention.
Interactions
Drug Interactions
Temazepam may interact with other medications that depress the central nervous system, such as opioids, antihistamines, and muscle relaxants. These interactions can increase the risk of adverse effects, including excessive sedation and respiratory depression.
Alcohol and Food Interactions
Alcohol should be avoided while taking temazepam, as it can enhance the sedative effects of the medication and increase the risk of side effects. There are no known significant food interactions with temazepam.
Contraindications
Conditions for Avoidance
Temazepam is contraindicated in patients with a history of hypersensitivity to benzodiazepines, severe respiratory insufficiency, or sleep apnea syndrome. It should also be avoided in patients with myasthenia gravis, severe liver impairment, or acute narrow-angle glaucoma.
Precautions
Use in Specific Populations
Temazepam should be used with caution in elderly patients, as they may be more sensitive to the effects of benzodiazepines and at higher risk for falls and cognitive impairment. Pregnant women should avoid using temazepam, as it may cause fetal harm, and the medication can pass into breast milk, potentially causing sedation in nursing infants.
Warnings for Operating Machinery or Driving
Patients should be warned about the potential for impaired mental alertness and motor coordination while taking temazepam, especially during the first few days of treatment. They should be advised not to drive or operate heavy machinery until they know how the medication affects them.
Pharmacology
Mechanism of Action
Temazepam, like other benzodiazepines, enhances the activity of GABA, the primary inhibitory neurotransmitter in the central nervous system. By binding to the GABA-A receptor complex, temazepam increases the frequency of chloride channel opening, leading to hyperpolarization of the neuron and reduced excitability, resulting in sedative, hypnotic, and anxiolytic effects [4].
Pharmacokinetics
Temazepam is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1-2 hours. It is extensively metabolized in the liver by the cytochrome P450 enzyme system, primarily CYP3A4, and has a half-life of 8-22 hours. The majority of the drug is excreted in the urine as conjugated metabolites.
Brand Names and Availability
Temazepam is available under the brand name Restoril in the United States, as well as various generic formulations. It is supplied as oral capsules in strengths of 7.5 mg, 15 mg, 22.5 mg, and 30 mg.
Regulatory Status and Legal Aspects
Temazepam is classified as a Schedule IV controlled substance in the United States, indicating a low potential for abuse and dependence compared to Schedule III drugs. It is available by prescription only and is subject to strict record-keeping and dispensing regulations.
Temazepam vs. Other Sleep Medications
Temazepam is one of several benzodiazepines used to treat insomnia, along with triazolam, flurazepam, and estazolam. It is considered an intermediate-acting benzodiazepine, with a slower onset and longer duration of action compared to triazolam but shorter than flurazepam. Non-benzodiazepine sleep aids, such as zolpidem and eszopiclone, have a similar efficacy to temazepam but may have a more favorable side effect profile and lower risk of dependence.
Patient Information
Patients should take temazepam exactly as prescribed by their healthcare provider, usually once daily before bedtime. If a dose is missed, it should be skipped, and the regular dosing schedule should be resumed the following day. Patients should not increase the dose or take temazepam for longer than prescribed without consulting their doctor. Temazepam should be stored at room temperature, away from light and moisture, and out of the reach of children.
Clinical Studies and Research
Numerous clinical trials have demonstrated the efficacy of temazepam in treating insomnia, with improvements in sleep onset, maintenance, and quality compared to placebo [5]. Recent research has focused on optimizing the use of temazepam, such as studying lower doses to minimize side effects and evaluating its use in specific patient populations, such as older adults with insomnia.
References
- Temazepam in the Treatment of Insomnia
- Restoril ( Temazepam) Capsules FDA Label
- Temazepam – StatPearls
- GABA Receptors as Targets for Neurodevelopmental Disorders
- Temazepam: A Review of its Pharmacological Properties and Therapeutic Efficacy as an Hypnotic
